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SUMMARY
The regeneration capacity of neonatal mouse heart is controversial. In addition, whether epicardial 
cells provide a progenitor pool for de novo heart regeneration is incompletely defined. Following 
apical resection of the neonatal mouse heart, we observed limited regeneration potential. Fate-
mapping of Tbx18MerCreMer mice revealed that newly formed coronary vessels and a limited 
number of cardiomyocytes were derived from the T-box transcription factor 18 (Tbx18) lineage. 
However, further lineage tracing with SM-MHCCreERT2 and Nfactc1Cre mice revealed that the new 
smooth muscle and endothelial cells are in fact derivatives of pre-existing coronary vessels. Our 
data show that neonatal mouse heart can regenerate but that its potential is limited. Moreover, 
although epicardial cells are multipotent during embryogenesis, their contribution to heart repair 
through “stem” or “progenitor” cell conversion is minimal after birth. These observations suggest 
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that early embryonic heart development and postnatal heart regeneration are distinct biological 
processes. Multipotency of epicardial cells is significantly decreased after birth.
Graphical Abstract
In Brief
The regeneration potential of the newborn mouse heart is controversial, and whether epicardial 
cells provide progenitors for coronary vascular regeneration is unclear. Cai et al. demonstrate a 
limited regeneration capacity of the neonatal heart upon injury. Epicardial cells do not convert into 
functional cardiac cells, including coronary vessels, during repair.
INTRODUCTION
Acute myocardial infarction from coronary artery occlusion and ischemia is a major cause of 
death worldwide. Lack of regeneration with fibrogenic response to the acute injury is the 
main obstacle in treatment of cardiovascular disease (Laflamme and Murry, 2011). 
Replacing the scarred tissue with new functional cardiac cells is a potential therapeutic 
strategy to patients with heart failure (Jopling et al., 2010; Poss et al., 2002).
Although the mammalian heart lacks sufficient regeneration capacity at adulthood, a few 
studies have shown that the neonatal mouse heart can fully regenerate after injury (Bryant et 
al., 2015; Haubner et al., 2012; Porrello et al., 2011; Strungs et al., 2013). Similar to the 
teleosts, injury-induced neonatal mouse heart regeneration is initiated with rapid clotting and 
inflammatory and epicardial activation (Han et al., 2015; Lepilina et al., 2006; Porrello et al., 
2011; Uygur and Lee, 2016). These observations revealed that within a short time window 
after birth, the mammalian hearts retain robust regeneration capacity (Haubner et al., 2012; 
Porrello et al., 2011). However, arguments arose recently concerning this capacity (Andersen 
et al., 2014; Andersen et al., 2016; Bryant et al., 2015; Kotlikoff et al., 2014; Polizzotti et al., 
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2016; Polizzotti et al., 2015), as they conversely reported that neonatal mouse hearts lack 
regeneration potential following apical resection or cryoinjury.
Despite the regeneration capacity of neonatal mouse heart, stimulation renewal of adult 
cardiac muscles remains challenging (Cai et al., 2003; Laflamme and Murry, 2011; 
Leferovich et al., 2001; Poss et al., 2002). Thus, identifying an optimal source of cardiac 
stem cells that can differentiate into different types of cardiac cells has been deemed an 
alternative approach for heart repair (Beltrami et al., 2003; Dawn et al., 2005; Orlic et al., 
2001). Epicardial cells are multipotent cardiac progenitor cells during embryonic 
development (Cai et al., 2008; Limana et al., 2007; Zhou et al., 2008). In zebrafish and mice, 
a fetal epicardial gene expression program is immediately activated following cardiac injury 
(Han et al., 2015; Lepilina et al., 2006; Limana et al., 2010; Limana et al., 2007; Porrello et 
al., 2011; Uygur and Lee, 2016). However, it failed to identify epicardium-derived 
cardiomyocytes during heart regeneration in zebrafish (Kikuchi et al., 2011). In mice, it is 
not fully determined whether postnatal epicardial cells can differentiate into different cardiac 
lineages after injury. With Wilms tumor suppressor 1 (Wt1) lineage tracing of the adult 
epicardial cells, van Wijk et al. (2012) detected myocardial cells derived from epicardial 
mesenchyme post-infarction. Smart et al. (2011) also identified epicardial differentiation 
into cardiomyocytes, and this differentiation potential is enhanced upon thymosin β4 
treatment. In contrast, Zhou et al. (2011) showed that epicardial cells only benefit heart 
repair through paracrine effects. Besides these unsolved critical issues regarding the 
epicardial myogenic potential, it is still uncertain whether postnatal epicardial cells sustain 
their potency and provide precursors for neovascularization during heart repair (Cai et al., 
2008; Katz et al., 2012; Limana et al., 2007; Mikawa and Fischman, 1992; Mikawa and 
Gourdie, 1996; Zhou et al., 2008).
In this study, to define the regeneration potential and epicardial “progenitor” or “stem” 
activity in the injured neonatal mouse heart, we scrutinized the heart with apical resection. 
Through an inducible Tbx18-MerCreMer (Tbx18MerCreMer/+) knockin allele that labels 
epicardial cells, we observed that although the neonatal hearts can regrow, their regenerative 
potential is restricted. We further uncovered that smooth muscle cells within the newly 
formed coronary vessels are derived from transcription factor T-box 18 (Tbx18) and smooth 
muscle myosin heavy chain (SM-MHC) cells through angiogenesis. The new coronary 
endothelial cells are also derivatives of the pre-existing cardiac endothelium. While Tbx18 
epicardial cells can give rise to cardiomyocytes, the number is exceedingly low and appears 
not to substantially contribute to a functional heart repair.
RESULTS
Extended Repair Process in the Neonatal Mouse Heart after Apex Amputation
To investigate neonatal mouse heart regeneration, we resected the lower portion of 
ventricular apex (~10% of the heart) at postnatal day 1 (P1) (Porrello et al., 2011). After 
amputation, the blood clotted immediately and the entire apex was sealed 3 hours after 
injury (Figure S1). Criteria to determine heart regeneration were based on several key factors 
including smoothness and thickness of apex, apical shape (curved or flat), and the presence 
of fibrotic tissues in the injured area.
Cai et al. Page 3
Cell Rep. Author manuscript; available in PMC 2019 November 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
We first examined the hearts at 7 days post-surgery (dps). Scars with rugged edges were 
observed (Figure S2). Haemotoxylin & Eosin (H&E) and trichrome staining were performed 
to determine how neonatal heart responds to amputation. Deposition of extracellular matrix 
was evident in the injured area at an early stage (Figure 1D2). After 7 dps, progressive repair 
with myocardial restoration was detected in the apex (Figure 1, 14–60 dps). However, by 
examining 59 hearts at 21 dps, we found that the time needed for repair was much longer 
than that which was previously reported (Porrello et al., 2011). Of 32 representative hearts, 
28 (87.5%) still had substantial fibrotic tissues in the apex (Figure 1D4 and Figures 2A, B, 
and E), suggesting most hearts were not fully regenerated by 21 dps, in contrast to that 
which was suggested previously (Porrello et al., 2011).
We then examined the injured hearts at later stages. In 108 hearts collected at 60 dps, 26 
were subjected to further histological analysis. Although 53.8% of them (14/26; Figure 2E) 
showed reconstruction with residual fibrotic tissues (Figure 1D6 and Figures 2C1, 2C2, 
2D1, and 2D2; Figure S2B6), a large number (46.2%, 12/26; Figure 2E) still did not exhibit 
full regeneration. Damage to this group seems permanent because their apical shape did not 
retrieve (Figures 2C3–2C5 and 2D3–2D5; Figure S2B6). Substantial fibrotic tissues were 
persistently present in the injured region of these hearts when we examined at 90–180 dps 
and later (data not shown). Moreover, when we inspected the “regenerated” group hearts at 
60 dps by comparing them with the sham group, it showed that although the apical edge of 
hearts in this group was relatively smooth with minimal fibrotic tissues, the global 
morphology was altered to a more “rounded” shape, characterized by significantly increased 
ventricular horizontal width to vertical height ratio (Figures 2F–2H).
Severe Injury Promotes Myocardial Proliferation after 21 dps
Mammalian myocardial cells progressively decrease their proliferation activity after birth, 
with <1% turnover rate per year at adulthood (Bergmann et al., 2009; Li et al., 1996; 
Mollova et al., 2013; Naqvi et al., 2014; Senyo et al., 2013; Soonpaa and Field, 1997; 
Soonpaa et al., 1996; Walsh et al., 2010; Zhang and Kühn, 2014). In mice, cardiomyocytes 
maintain their cell cycle till 21 days after birth, and it showed that the neonatal heart fully 
regenerated with myocardial turnover by 21 dps (Porrello et al., 2011). We decided to assess 
the course of myocardial repair after 21 dps (Figures 2C–2E), given the improved repair rate 
or degree at 21–60 dps (Figure 2E). A 5-ethynyl-2’-deoxyuridine (EdU) pulse-chase assay 
was conducted to determine if myocardial proliferation continually contribute to heart repair 
after 21 dps. Mice were injected intraperitoneally with EdU at P21/P28 and P32/39, 
respectively (Figure 3A). Proliferative myocardial cells were identified by colocalization of 
EdU, cardiac troponin T (cTnT), and DAPI at 32 dps and 43 dps. Compared with the sham 
group, an increased number of EdU-positive (EdU+) cells were detected in the apex and 
remote region of injured hearts (32 dps: ~34.5 cells and ~26.1 cells/100× field in apex and 
remote region versus ~11.0 cells and ~10.7 cells/100× field in the sham apex and remote 
region; 43 dps: ~34.9 cells and ~23.7 cells/100× field in the injured apex and remote region 
versus ~12.1 cells and ~12.5 cells/100× field in the sham apex and remote region, Figures 
3B–J), suggesting that the apical injury promotes global cardiac cell proliferation at 21–43 
dps, although most of them are non-cardiomyocytes (cTnT−; Figures 3C2 and 3G2). Further 
evaluation revealed an increased number of EdU+ cardiomyocytes in the injured apex border 
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zone at 32 dps and 43 dps (~3.0 cells and ~2.3 cells/100× field, respectively) (Figures 3C1, 
3G1, and 3K), and the number was significantly higher than that of the sham-operated 
controls (~0.2 cells and ~0.07 cells/100× field at 32 dps and 43 dps, respectively) (Figures 
3E1, 3I1, and 3K). The plasma membrane marker wheat germ agglutinin (WGA) was used 
to identify the true proliferation of cardiomyocytes as opposed to binucleation (Figure S3). 
These observations indicate that severe injury can induce myocardial proliferation after 21 
dps.
Tbx18-Expressing Cells Contribute to Heart Repair
The transcription factor Tbx18 is expressed in the epicardium across species in vertebrates 
(Haenig and Kispert, 2004; Kraus et al., 2001). Previous studies suggested that epicardial 
cells are cardiac progenitors and give rise to multiple cardiac lineages, including coronary 
smooth muscle cells (cSMCs), endothelium, fibroblasts, and cardiomyocytes, during 
embryonic heart formation (Cai et al., 2008; Katz et al., 2012; Mikawa and Fischman, 1992; 
Mikawa and Gourdie, 1996; Zhou et al., 2008). To determine the potential de novo 
contribution of epicardial progenitor cells through differentiation in heart repair, we 
performed apical resection on Tbx18H2B-GFP/+ mice at P1. H2B-GFP in Tbx18H2B-GFP/+ 
knockin reporter mice recapitulates endogenous Tbx18 expression (Cai et al., 2008), and the 
mice carrying heterozygous null for Tbx18 are normal in heart formation and function (Wu 
et al., 2013). Upon surgical amputation, massive Tbx18H2B-GFP-positive cells accumulated 
in the ventricular apex at 3 dps (Figures 4A1, 4B1, and 4C1). Density of these GFP+ cells 
was high at 1–21 dps (Figures 4A1–4A4, 4B1–4B4, and 4C1–4C4) and slowly decreased 
after 30 dps (Figures 4A5, 4A6, 4B5, 4B6, 4C5, and 4C6). To determine the cause of 
reduction of Tbx18+ cells during heart repair, we performed TUNEL (terminal 
deoxynucleotidyl transferase dUTP nick-end labeling) staining on the injured heart. 
Apoptotic Tbx18+ cells were detected in the injured area throughout the heart repair process 
(Figure S4), indicating apoptosis could be the cause of reduction. An increased number of 
Tbx18+ cells were not detected in the sham group (Figures 4A7, 4B7, and 4C7).
We further performed immunostaining to define cell type of these Tbx18+ cells. With tissues 
at all stages tested (3, 7, 14, 21, 30, and 60 dps), Tbx18H2B-GFP-positive cells were not co-
expressed with cTnT or platelet endothelial cell adhesion molecule (PECAM/CD31), 
indicating they are not cardiomyocytes or endothelial cells (Figures 4D1, 4D5, 4E1, and 
4E5). In contrast, a subpopulation of Tbx18H2B-GFP-positive cells were co-expressed with 
smoothel muscle α-actin (α-SMA), SM-MHC, or platelet-derived growth factor receptor 
beta (PDGFRβ), which are markers for vascular smooth muscle cells (SMCs) and pericytes 
(Figures 4D2–4D4 and 4E2–4E4). We also found that some Tbx18+ cells were co-expressed 
with CD90 and PDGFRα, markers for cardiac fibroblast (Acharya et al., 2012; Hudon-
David et al., 2007; Ivey and Tallquist, 2016; Smith et al., 2011; Travers et al., 2016) (Figure 
S5). This demonstrates that at least a subpopulation of Tbx18-expressing cells are SMCs and 
pericytes and a portion of Tbx18+ cells are fibroblasts in the injured area.
We next attempted to determine the differentiation potential of Tbx18+ cells to heart repair 
with a Tbx18MerCreMer/+ knockin allele, in which a MerCreMer cassette was inserted into 
the start codon of Tbx18 to induce Cre expression under full Tbx18 regulatory elements 
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upon tamoxifen induction (Figure S6A). To avoid interference by cardiomyocytes from 
embryonic epicardial cells during heart development (Cai et al., 2008; Zhou et al., 2008), 
Tbx18MerCreMer/+ mice were crossed with R26RGFP reporter mice and the compound 
heterozygous (Tbx18MerCreMer/+;R26RGFP) mice were injected with tamoxifen at P0 (Figure 
5). This enabled us to specifically label Tbx18-expressing cells after birth. Cre efficiency 
was confirmed by robust GFP expression in the limb of the newborn 
Tbx18MerCreMer/+;R26RGFP mice after tamoxifen administration (Figure S6C). With cardiac 
tissues collected at P30, we did not detect co-localization of GFP with myocardial markers 
cTnT and Nkx2.5 or endothelial cell marker PECAM (Figure 5). However, co-expression of 
GFP with SM-MHC and α-SMA was found. This further confirmed that Tbx18 is actively 
expressed in SMCs but not in endothelial cells or cardiomyocytes after birth, as illustrated 
with Tbx18H2B-GFP/+ reporter mice (Figure 4).
To trace the progeny of Tbx18-expressing cells after injury, 
Tbx18MerCreMer/+;R26RtdTomato/+ compound heterozygous mice were subjected to apex 
resection followed by tamoxifen administration (Figure 6). With the hearts harvested at 30 
dps and 60 dps, we did not detect any Tbx18-derived cardiomyocytes (cTnT+/tdTomato+ 
double positive) in areas distant from the injured area (Figure 6C) or in the sham group 
hearts (Figure 6D). A few cTnT+ cardiomyocytes were found in the injured apex at both 
stages examined (Figures 6A, 6B, 6E, and 6F). However, the number is extremely low 
(fewer than 30 cells in the entire injured region). To verify this, a parallel study with 
Tbx18MerCreMer/+;R26RlacZ/+ mice was performed. Cardiomyocytes from Tbx18 lineage 
(lacZ+) were detected in the newly formed apex at 60 dps (Figures 6G4–6G6) and the 
incidence was also remarkably rare (fewer than 35 cells in the whole heart). This revealed 
that although Tbx18+ cells can turn into cardiomyocytes, their potential is exceedingly low 
in the injured heart. Most cardiomyocytes are not progeny of Tbx18-expressing cells 
(Figures 6G2–6G4).
We further inquired if the newly formed cSMCs and endothelium are Tbx18 epicardial 
derivatives, given that epicardial progenitors give rise to cSMCs (Cai et al., 2008; Katz et al., 
2012; Mikawa and Fischman, 1992; Mikawa and Gourdie, 1996; Zhou et al., 2008) and 
endothelium (Katz et al., 2012; Mikawa and Fischman, 1992; Zhou et al., 2008) during 
embryonic heart development. Surgeries, genetic tracing of Tbx18 lineage, and tamoxifen 
induction were performed on Tbx18MerCreMer/+;R26RtdTomato/+ mice. Upon 
immunohistochemistry with cardiac tissues collected at 21 dps and 60 dps, we detected co-
localization of cSMCs (SM-MHC+) with tdTomato (Tbx18-expressing or progeny) in the 
apex (Figures 6H and 6I). In contrast, no co-localization of the PECAM+ coronary 
endothelium with tdTomato was found (Figures 6J and 6K), suggesting that cSMCs, but not 
endothelial cells, in the newly formed coronary vessels are derivatives of Tbx18-expressing 
cells.
Angiogenic Process Contributes to the New Coronary Vessel Formation
The newly formed cSMCs could differentiate de novo from Tbx18+ epicardial cells or they 
could be derived from the pre-existing Tbx18+ cSMCs through angiogenesis, given that 
Tbx18 is actively expressed in both epicedial cells and cSMCs after birth (Figures 4 and 5). 
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We therefore attempted to determine the ultimate origin of cSMCs in the new coronary 
vessels of injured hearts.
SM-MHC-CreERT2 transgenic mice specifically label SMCs upon tamoxifen induction 
(Wirth et al., 2008). We crossed SM-MHC-CreERT2 with R26RmT/mG (R26RtdTomato/GFP) 
mice and compound heterozygous animals (SM-MHC-CreERT2; R26RmT/mG) were injected 
with tamoxifen at E13.5 and E16.5. We found SM-MHC-CreERT2 effectively labels cSMCs 
at birth (Figure 7A). Littermates were subjected to cardiac apical injury at P1. By 
immunohistochemistry of hearts collected at 30 dps and 60 dps, we detected that all the 
cSMCs (α-SMA+) in the remote area are GFP-positive (GFP+), indicating effective labeling 
of the pre-existing cSMCs. When examining the injured area, we observed that new SMCs 
are constantly GFP+ (Figure 7B–7D), demonstrating that they are derivatives of the pre-
existing GFP+ cSMCs rather than through cell fate conversion from Tbx18+ epicardial cells.
As discussed above, Tbx18-expressing cells do not convert to coronary endothelium and the 
origin of a new coronary endothelium is inconclusive with Tbx18MerCreMer/+;R26RtdTomato/+ 
mouse models (Figures 6J and 6K). We then utilized Nfatc1Cre mice to mark pre-existing 
coronary endothelium. Nfatc1 (nuclear factor of activated T cells, cytoplasmic 1) is a 
transcription factor specifically expressed in the early endocardial precursors and sinus 
venosus before they become endothelium during embryogenesis (Chen et al., 2014; Tian et 
al., 2015; Wu et al., 2012). Nfatc1 is not expressed in the differentiated cardiac endothelium 
after birth (Chen et al., 2014; Tian et al., 2015; Wu et al., 2012). Nfatc1Cre progeny 
encompass most coronary endothelium during heart formation (Cai et al., 2013; Chen et al., 
2014; Wu et al., 2012). By examining Nfatc1Cre/+;R26RtdTomato/+ hearts at P0, P30, and P60, 
we found Nfatc1 lineages constitute most PECAM+ coronary endothelium in the ventricular 
apex (Figure 7E; data not shown). We applied Nfatc1Cre/+;R26RtdTomato/+ mice to label the 
existing coronary endothelium, and surgical resection was performed on these animals at P1. 
With these animals, if tdTomato− and PECAM+ coronary endothelial cells were present in 
the apex, it would indicate that they are not from pre-existing endothelial cells. In fact, we 
found PECAM+ cells in the injured area (including the border zone) were always tdTomato
+
 (60 dps, Figure 7F), suggesting that the pre-existing endothelial cells made complete 
contributions to the new coronary endothelial formation through angiogenesis (instead of 
through vasculogenesis from cardiac “progenitor” cells).
DISCUSSION
Regeneration Capacity of the Neonatal Mouse Heart Is Restricted
The regeneration potential of the neonatal mouse heart is controversial (Andersen et al., 
2014; Andersen et al., 2016; Haubner et al., 2012; Kotlikoff et al., 2014; Polizzotti et al., 
2015; Porrello et al., 2011; Sadek et al., 2014; Strungs et al., 2013). Previous report showed 
that, with surgical resection of 15% of ventricular myocardium in apex, the mouse heart can 
fully regenerate within 21 days (Porrello et al., 2011). Here, we show that most injured 
hearts (87.5%) had substantial fibrotic tissues at 21 days, demonstrating that the time needed 
for restoration is much longer than that reported (Porrello et al., 2011). Likewise, 
regeneration of resected zebrafish heart is not accomplished until after 60 days (Poss et al., 
2002).
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At 60 dps, we found only half of the injured hearts (53.8%) restored or regenerated with 
collagen residues, and a large portion (46.2%) still displayed incomplete repair with fibrotic 
tissues. Even in the “regenerated” group, overall morphology of the heart is inevitably 
changed to a “rounded” shape (Figure 2). A long-term follow up of cardiac regeneration at 
180 dps showed that apex resection of P1 mice resulted in irreversible fibrosis and dilated 
cardiomyopathy (Andersen et al., 2014; Andersen et al., 2016). Our data support the notion 
that the newborn mouse heart can repair; however, its regeneration potential is apparently 
restricted but not unlimited (even with 10% ventricular apex amputation as demonstrated in 
this study). The prolonged repair process and variable regeneration capacity may be due to 
severity of the injury and actual surgical procedure to the hearts (Andersen et al., 2014; 
Bryant et al., 2015; Darehzereshki et al., 2015; Konfino et al., 2015). However, if the injury 
of this study is “more severe” than that which has been reported elsewhere, it should indicate 
that larger injuries do not necessarily result in a proportionally greater regenerative response 
but enhanced fibrosis (Bryant et al., 2015), further demonstrating “limited” regeneration 
capacity in the neonatal mouse heart. Nevertheless, it may be important to assess the 
regeneration potential of the neonatal mouse heart following small, large, superficial, and 
transmural infarcts in order to determine the physiological limits (Porrello and Olson, 2014). 
Moreover, with the increased restoration rate of the injured heart from 21 dps (12.5%) to 60 
dps (53.8%), it appears that severe injury leads to an extended repairing time window 
(prolonged myocardial proliferation after 21 dps).
Multipotency of Epicardial Cells Is Eliminated in Postnatal Heart Repair
Epicardial activation was found in zebrafish and mouse hearts upon acute injury (Huang et 
al., 2012; Kikuchi et al., 2010; Lepilina et al., 2006; Limana et al., 2010; Zhou et al., 2011). 
Our study consistently showed accumulation of Tbx18+ cells in the injured area upon apex 
resection. The multidirectional differentiation potential of epicardial cells during embryonic 
development (Cai et al., 2008; Kikuchi et al., 2011; Limana et al., 2007; Zhou et al., 2008) 
suggests they may act as progenitor cells in the neonatal and adult heart repair. As of today, 
whether postnatal epicardial cells are multipotent and contribute to heart repair is not fully 
defined. Lineage tracing with Wt1Cre mouse showed that Wt1+ epicardial cells differentiated 
into cardiomyocyte after myocardial infarction (van Wijk et al., 2012). Studies with the Wt1-
CreERT2 mouse model did not find conversion of cardiomyocytes from epicardial cells in 
the adult heart (Zhou et al., 2011). In this study, only a very limited number of 
cardiomyocytes from Tbx18+ cells were detected, suggesting that myocardial potential of 
these cells is extremely low and does not contribute to a functional myocardial repair after 
birth.
Epicardial cells are precursors that give rise to coronary SMCs and possibly endothelial cells 
during embryonic heart formation (Cai et al., 2008; Katz et al., 2012; Mikawa and 
Fischman, 1992; Mikawa and Gourdie, 1996; Zhou et al., 2008). Despite their potential 
during development, our lineage tracing results show that postnatal epicardial cells 
minimally convert to cardiac endothelium. Nfatc1Cre/+;R26RtdTomato/+ and SM-MHC-
CreERT2;R26RtdTomato/GFP models suggest that new coronary vasculatures are derived from 
the pre-existing coronary endothelium and cSMCs after injury. These observations reveal 
that coronary formation during embryonic development and neovascularization upon injury 
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are distinct biological processes. The multipotent nature of embryonic epicardial cells 
significantly decreases after birth.
In summary, our studies suggest a limited regeneration potential of the neonatal heart upon 
injury, and postnatal epicardial cells generally do not convert into functional cardiac cells 
during heart repair, including neovascularization. In the future, it will be of interest to 
compare embryonic, neonatal, and adult epicardial cells in order to define molecular basis 
underlying the change of their potency.
STAR★METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Chen-Leng Cai (chenleng@iu.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Wild-type CD1 mice were obtained from Charles River Laboratories.: Tbx18H2B-GFP/+, 
SM-MHCCreERT2 and Nfatc1Cre mice were described previously (Cai et al., 2008; Wirth et 
al., 2008; Wu et al., 2012). To create Tbx18MerCreMer/+ knockin line, a MerCreMer cassette 
followed by a Neomycin resistance gene was introduced into the mouse Tbx18 start codon 
through gene targeting. Animals derived from the positive embryonic stem cells were 
crossed to a Flippase deleter (FLPe) line to remove the Neomycin cassette (Rodríguez et al., 
2000). Rosa26 reporter lines, including R26RlacZ/+,R26RGFP/+,R26RtdTomato/+ and 
R26RtdTomato/GFP (R26RmT/mG or R26Rm-tdTomato/m-GFP) were obtained from Jackson 
Laboratories (Bar Harbor, ME) (Madisen et al., 2010; Muzumdar et al., 2007; Soriano, 
1999). Genetically modified mouse models were bred in a Black Swiss background. 
Experiments with animal models were performed in accordance with the guidelines and 
approval of the Institutional Animal Care and Use Committee (IACUC) at the Icahn School 
of Medicine at Mount Sinai and Sun Yat-sen University Zhongshan Medical School.
Animal models with cardiac surgery: The apical resection of neonatal mouse hearts was 
performed as described by Porrello et al. with modifications (Porrello et al., 2011). Briefly, 
postnatal day 1 (P1) mice were anesthetized by cooling on an ice bed for 4 minutes, and 
subsequently a left lateral thoracotomy was made in the fourth or fifth intercostal space 
following skin incision. Under direct stereo-microscopic visualization, the pericardial sac 
was opened, and the heart apex was held with a 200 μL pipette tip connected to an adjusted 
bench vacuum. The ventricular apex was resected with iridectomy scissors when the left 
ventricular chamber was exposed. Approximately 10% (10.5 ± 1.81% of the total heart by 
weight) cardiac tissues were removed. After the injury, the animals were gently moved back 
to the ice bed to minimize bleeding, and then the thoracic wall incisions and the skin wound 
were sutured (7-0 silk suture). For sham group, a similar thoracotomy procedure was 
performed without apical resection. The postsurgical neonates were transferred onto a 
temperature-controlled pad (37°C) for several minutes. After recovery from anesthesia, the 
pups were put back with their mothers, and the wound generally healed in 4-5 days. Cardiac 
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regeneration was evaluated with several criteria, including defects in the injury site, 
smoothness of apex edge, amount of fibrosis and thickness of the apex.
METHOD DETAILS
Tamoxifen administration—Tamoxifen (T5648, Sigma-Aldrich, St Louis, MO, USA) 
was dissolved in ethanol (10%) and sesame oil (90%) solution to a final concentration of 10 
mg/ml. Cre recombinase translocation was triggered by intraperitoneal injection of 30 μL 
tamoxifen solution in the neonatal pups (P0). For SM-MHC-CreERT2;R26RmT/mG reporter 
mouse, pregnant female mice were given tamoxifen by intraperitoneal injection with the 
dose of 100 μg/g body weight once when embryos were at E13.5 and E16.5. All newborn 
mice at P1 underwent apical resection.
Cardiac morphology analysis—For histology, dissected hearts were immersed in 10% 
potassium chloride for 5 min and allowed to stop at diastole. After washed in PBS, the hearts 
were fixed in 4% paraformaldehyde/PBS for 1-2 hours (10min fixation for the hearts with 
fluorescence proteins) and were then transferred into 20% sucrose/PBS at 4°C for 2 hours. 
Subsequently, hearts were embedded in TissueTek OCT compound. Cryosections were cut at 
6-8 μm thickness using a Leica cryostat. Hematoxylin/eosin staining was performed with 
standard procedures (Cai et al., 2013). Masson’s trichrome staining was performed with a kit 
from Sigma (HT15-1KT).
For global cardiac morphology and shape assessment, the hearts were immediately 
immersed in 15% potassium chloride solution after dissection. Ventricular maximal 
horizontal diameter (width, w) and vertical diameter (height, h) was measured on the whole-
mount images in Photoshop CS software (Adobe, CA, USA). Ratio (w/h) is calculated for 
quantitative and statistical analysis.
Immunohistochemistry and antibodies—Tissue cryosections were rinsed in PBS to 
remove OCT and blocked at room temperature for 1 hour (5% BSA and 0.1% Triton X-100 
in PBS). Subsequently, sections were incubated in the primary antibody for 1–2 hours. After 
washing 3 times (0.1% Triton X-100 in PBS), the samples were incubated in the secondary 
antibody in the blocking buffer for 1 hour at room temperature. Sections were mounted with 
DAPI to detect nuclei. Fluorescent images were captured using an upright Leica 
fluorescence microscope.
The following antibodies were used: chicken anti-GFP (1:1000, ab13970, Abcam, 
Cambridge, UK), mouse monoclonal anti-cTnT (1:1000, TI-1, DSHB, Iowa, USA), rat anti-
CD31 (1:500, No.550274, BD PharMingen, Palo Alto, CA), rabbit monoclonal anti-
PDGFRβ (1:200, ab32570, Abcam, Cambridge, UK), goat anti-Nkx2.5 (1:150, SC-8697, 
Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse monoclonal anti-α-SMA (1:500, 
A5228, Sigma-Aldrich, St Louis, MO, USA), rabbit anti-SM-MHC (1:250, BT-562, 
Biomedical Technologies Inc., Stoughton, MA, USA), rabbit polyclonal anti-Tbx18 (1:200, 
ab115262, Abcam, Cambridge, UK), mouse monoclonal anti-CD90 (1:200, ab225, Abcam, 
Cambridge, UK), mouse monoclonal anti-PDGFRα (1:200, ab96569, Abcam, Cambridge, 
UK) and WGA-Alexa488 (1:100, W6748, Invitrogen, USA).
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The following secondary antibodies were used in this study: Alexa 594 donkey anti-rabbit 
IgG (A21207, Thermo Fisher, Grand Island, NY, USA), Alexa 488 goat anti-chicken IgG 
(A11039, Thermo Fisher), Alexa 594 donkey anti-goat IgG (A11058, Thermo Fisher), Alexa 
594 donkey anti-rat IgG (A21209, Thermo Fisher), Alexa 594 goat anti-mouse IgG2a 
(A-21135, Thermo Fisher) and Dylight 488 rabbit anti-chicken IgY (ab96955, Abcam, 
Cambridge, UK). The secondary antibodies were diluted at 1:500 in blocking solution.
X-gal Staining—Hearts were harvested and fixed in 4% paraformaldehyde at 4°C for 25 
minutes. They were transferred to sucrose solution and embedded in OCT compound as 
described above. Cryosections (12 μm) were prepared and stained for β-galactosidase 
activity with X-gal solution (50 mM K-ferricyanide, 50 mM K-ferrocyanide, 200 mM 
MgCl2, and 100 mg/ml X-gal in PBS) at 37°Cfor 12 hours. Sections were rinsed in PBS, 
counterstained and mounted as needed.
EdU pulse-chase analysis—EdU was dissolved in PBS and injected intraperitoneally 
into the mice (5 mg per 100 g body weight) after injury. The hearts were harvested on the 
4th day after the last EdU injection. Immunodetection of the proliferative cells was 
performed using a Click-iT EdU Cell Proliferation Assay Kit (C35002, Thermo Fisher).
Cell apoptosis analysis—Tissue cryosections were rinsed in PBS to remove OCT and 
blocked at room temperature for 1 hour (5% BSA and 0.1% Triton X-100 in PBS). 
Apoptotic cells were labeled using the Click-iT Plus TUNEL Assay for In Situ Apoptosis 
Detection (C10617, Thermo Fisher).
QUANTIFICATION AND STATISTICAL ANALYSIS
All data are presented as the mean ± standard error of the mean (SEM). Student’s unpaired t 
test was used for the comparisons between the sham and resected groups. A value of p < 
0.05 was considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Limited regeneration occurs in the neonatal mouse heart upon ventricular 
apex amputation
• Progenitor cell differentiation from epicardium is very minimal during heart 
repair
• New coronary vessels are generated through angiogenesis after injury
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Figure 1. Neonatal Heart Repair upon Ventricular Apex Resection
(A and B) Transverse sections of sham (A) and apex-resected hearts (B) at 3, 7, 14, 21, 30, 
and 60 dps.
(C and D) High magnification of apex indicates amputation and clot at 3 dps (C1 and D1), 
and repair at 7–60 dps (C2–C6 and D2–D6). Trichrome staining of serial sections revealed 
that the apex was sealed with a large amount of fibrin between 7–30 dps (D2–D5), and 
fibrosis was replaced by the reconstituted wall by 60 dps (D6).
Arrows indicate injury site. Scale bar, 1 mm.
See also Figures S1 and S2.
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Figure 2. Limited Potential of Neonatal Heart Regeneration
(A–D) Transverse sections of representative hearts at 21 dps (A and B) and 60 dps (C and 
D), suggesting that the repairing process takes longer than 21 days. A significant portion of 
hearts (46.2%) cannot be fully regenerated at 60 dps (C4 and C5). Asterisks indicate injured 
regions and incomplete repair.
(E) Quantification of repair degree at 21 dps and 60 dps determined by apex shape and 
fibrotic tissues.
(F–H) Global view of hearts in sham (F) and surgery (G) groups. Ventricular morphology is 
quantitated by the ratio of maximal horizontal width (w) to maximal vertical height (h) (H).
**p < 0.01 versus the sham control. Scale bar, 1 mm.
See also Figures S1 and S2.
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Figure 3. Cell Proliferation in the Injured Hearts
(A) Diagram of pulse-chase EdU labeling of proliferating cells and the timeline for EdU 
injection and tissue collection.
(B–I) Co-localization of EdU, cTNT, and nuclei (DAPI) in the apex (B1, D1, F1, and H1) 
and remote areas (B2, D2, F2, and H2) at 21–32 dps (B–E) and 32–43 dps
(G–I) in the resected (B, C, F, and G) and sham (D, E, H, and I) groups. Asterisks indicate 
injury site. Arrows in (C1) and (G1) show EdU-positive cardiomyocytes, and arrows in (C2), 
(E), (G2), and (I) show EdU-positive non-cardiomyocytes (cTnT−).
(J and K) Quantification of EdU-labeled proliferative cells (J) and cardiomyocytes (K) in 
sham and resected hearts at 32 dps and 43 dps.
Quantitative analysis was performed on 5 fields at 100× magnification from 3 different 
hearts per group at each time point. *p<0.05, **p < 0.01 versus the control.
Scale bar, 100 μm (white) and 25 μm (yellow).
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See also Figure S3.
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Figure 4. Accumulated Tbx18-Expressing Cells in the Injured Region
(A) DAPI staining at 3, 7, 14, 21, 30, and 60 dps.
(B and C) Robust Tbx18-expressing cells (Tbx18H2B-GFP-positive) in the injury site during 
repair (arrows) with high density at 3–21 dps (B1–B4 and C1–C4).
(D and E) Immunostaining in the injured site at 21 dps (D) and 60 dps (E). Tbx18H2B-GFP is 
not co-expressed with cTNT (D1 and E1) but is co-expressed with SM-MHC (D2 and E2), 
α-SMA (D3 and E3), and PDGFRβ (D4 and E4). Tbx18H2B-GFP is not co-expressed with 
PECAM in the endothelial cells (D5 and E5). The top right corner images in (D) and (E) are 
high magnification of the areas outlined in each panel. Scale bar, 1mm (white) and 100 μm 
(yellow).
See also Figures S4 and S5.
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Figure 5. Tbx18+ Cells Do Not Become Cardiomyocytes or Coronary Endothelial Cells after 
Birth
The neonatal mice were given a single subcutaneous dose of tamoxifen at P0, and the hearts 
were collected at postnatal day 30 for analysis.
(A and B) Tbx18 progeny do not include cardiomyocytes (not co-localized with cTNT, A, or 
Nkx2.5, B).
(C and D) Co-expression of Tbx18 progeny with SM-MHC (C4) and α-SMA (D4).
(E) Tbx18 lineage is not co-expressed with PECAM in the coronary endothelial cells (E4).
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(A1), (B1), (C1), (D1), and (E1) are DAPI staining. GFP-positive cells in (A2), (B2), (C2), 
(D2), and (E2) are cells of Tbx18 lineage. (A3), (B3), (C3), (D3), and (E3) are antibody 
staining for cTNT, Nkx2.5, SM-MHC, α-SMA and PECAM, respectively. (A4), (B4), (C4), 
(D4), and (E4) are overlays of (A1–A3), (B1–B3), (C1–C3), (D1–D3), and (E1–E3), 
respectively. Scale bar, 100 μm.
See also Figure S6.
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Figure 6. Tbx18 Lineage Analysis after Cardiac Injury
(A–K) Tbx18MerCreMer;R26RtdTomato (A–F and H–) and Tbx18MerCreMer;R26RlacZ (G) mice 
were injected with tamoxifen after apex resection.
(A–F) Immunostaining was performed on Tbx18MerCreMer;R26RtdTomato hearts at 30 dps 
(A–D) and 60 dps (E and F). Arrows in (A), (B), (E), and (F) indicate tdTomato and cTNT 
double-positive cells in the apex at 30 dps (A and B) and 60 dps (E and F). Arrows in (C) 
and (D) indicate non-myocardial Tbx18 lineage (cTnT−) in the remote area (C) or in the 
apex of sham group (D).
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(B–D and F) Right-bottom corner images are high magnification of the areas indicated by 
arrows.
(G) X-gal staining of Tbx18MerCreMer;R26RlacZ hearts revealed Tbx18-derived 
cardiomyocytes (arrows in G4–G6) in the apex at 60 dps. (G2), (G3), and (G4) are high 
magnification of the square areas in G1. (G5) and (G6) are high magnification of the square 
areas in (G4). Unnotched arrows (G2–G4) indicate X-gal negative cells.
(H–K) Immunostaining on Tbx18MerCreMer;R26RtdTomato hearts at 21 dps (H) and 60 dps 
(I). tdTomato signals (arrows) are co-localized with SM-MHC in the apex at 21 dps and 60 
dps (H and I). PECAM staining (unnotched arrows in J and K) is not co-localized with 
tdTomato (arrows) in the regenerative coronary at 21 dps and 60 dps. Right bottom corner 
images (H-K) are high magnification of areas indicated by notched arrows. Scale bar, 50 μm 
(white), 100 μm (black) and 20 μm (yellow).
See also Figure S6.
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Figure 7. New Coronary SMCs and Endothelial Cells within the Ventricular Apex Are Derived 
from the Pre-existing Coronary Vessels
(A) Immunostaining of SM-MHCCreERT2; R26RmT/mG hearts at P0 with tamoxifen 
induction during gestation.
(B–D) Hearts at 30 dps (B) and 60 dps (C and D) with apical resection at P1.
GFP+ cells (A1, B1, C1, and D1) are cells of SM-MHC lineage. (A2), (B2), (C2), and (D2) 
are antibody staining for α-SMA. (A3), (B3), (C3), and (D3) are overlays of SM-MHC 
lineage (GFP+) with DAPI and α-SMA. α-SMA+ SMCs in the injured apex are from SM-
MHC lineage (arrows in B3 and D3). Asterisk indicates injured area.
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(E and F) Regeneration of coronary endothelial after apical resection. Immunostaining of 
Nfatc1Cre/+;R26RtdTomato/+ hearts at 60 dps.
(E) Nfatc1 progeny give rise to coronary endothelium (arrows in E4).
(F) PECAM+ endothelial cells in the newly formed apex are from Nfatc1+ endocardial/
endothelial lineage (arrows in F4).
(E1) and (F1) are DAPI staining; (E2) and (F2) are PECAM staining; (E3) and (F3) are 
overlays of Nfatc1 lineage (tdTomato+) with DAPI. (E4) and (F4) are high-magnification 
images of the areas outlined in (E3) and (F3). They are overlays of PECAM staining and 
Nfatc1 lineage (tdTomato+). Scale bar, 100 μm.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Chicken anti-GFP Abcam Cat# ab13970; RRID:AB_300798
Mouse monoclonal anti-cTnT DSHB Cat#TI-1; RRID:AB_2206413
Rat anti-CD31 BD PharMingen Cat# 550274; RRID: AB_393571
Rabbit monoclonal anti-PDGFRβ Abcam Cat#ab32570; RRID:AB_777165
Mouse monoclonal anti-α-SMA Sigma-Aldrich Cat#A5228; RRID:AB_262054
Goat anti-Nkx2.5 Santa Cruz Biotechnology Cat#SC-8697; RRID:AB_650280
Rabbit anti-SM-MHC Biomedical Technologies Inc Cat#BT-562; RRID:AB_10013421
Rabbit polyclonal anti-Tbx18 Abcam Cat#ab115262
Mouse monoclonal anti-CD90 Abcam Cat#ab225; RRID:AB_2203300
Mouse monoclonal anti-PDGFRα Abcam Cat#ab96569; RRID:AB_10687154
WGA-Alexa488 Invitrogen Cat#W6748
Alexa594 donkey anti-rabbit IgG Thermo Fisher Cat#A21207; RRID:AB_141637
Alexa 488 goat anti-chicken IgG Thermo Fisher Cat#A11039; RRID:AB_142924
Alexa594 donkey anti-goat IgG Thermo Fisher Cat#A11058; RRID:AB_2534105
Alexa594 donkey anti-rat IgG Thermo Fisher Cat#A21209; RRID:AB_2535795
Alexa 594 goat anti-mouse IgG2a Thermo Fisher Cat#A21135; RRID:AB_1500827
Dylight 488 rabbit anti-chicken IgY Abcam Cat#Ab96955; RRID:AB_10679801
Chemicals, Peptides, and Recombinant Proteins
Tamoxifen Sigma-Aldrich Cat#T5648
Bouin’s Solution Sigma-Aldrich Cat#HT10-1-32
Weigert’s Iron Hematoxylin Set Sigma-Aldrich Cat#HT10-79
5-Bromo-4-chloro-3-indolyl-α-D-galactopyranoside Sigma-Aldrich Cat#16555
Critical Commercial Assays
Click-iT EdU Cell Proliferation Assay Kit Thermo Fisher Cat#C35002
Click-iT Plus TUNEL Assay for In Situ Apoptosis Detection Thermo Fisher Cat#C10617
Masson’s trichrome staining Sigma-Aldrich Cat#HT15-1KT
Experimental Models: Organisms/Strains
Mouse: B6.129S4-Gt(ROSA)26Sortm1Sor /J The Jackson Laboratory JAX: 003474
Mouse: B6;129-Gt(ROSA)26Sortm9(CAG-GFP*)Nat/J The Jackson Laboratory JAX: 026005
Mouse: B6;129-Gt(ROSA)26Sortm7(CAG-tdTomato*)Nat/J The Jackson Laboratory JAX: 026006
Mouse: B6.129(Cg)-Gt(ROSA)26 Sortm4(ACTB-tdTomato,-EGFP)Luo/J The Jackson Laboratory JAX: 007676
Mouse: Tbx18H2B-GFP Cai et al., 2008 N/A
Mouse: Tbx18MerCreMer/+ This paper N/A
Mouse: SM-MHCCreERT2 Wirth et al., 2008 N/A
Mouse: Nfatc1Cre Wu et al., 2012 N/A
Software and Algorithms
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REAGENT or RESOURCE SOURCE IDENTIFIER
Photoshop CS software Adobe https://www.adobe.com/cn/products/cs6/
photoshop.html
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